A new study from scientists at Penn State University shows that low-calorie sweeteners, when used in amounts typical for preparing foods and beverages, do not overstimulate a person’s sweet taste buds. These results provide additional evidence that low-calorie sweeteners do not lead to sweet cravings and can be a helpful …
Read More »Diabetes In Control
Sleep Apnea May Speed Kidney Decline
A new study found that diabetes patients who had sleep apnea lost kidney function more rapidly than those who did not have the sleep disorder. Researchers found that 61 percent of the patients had a high-risk score for obstructive sleep apnea and a much greater loss of kidney function. Sleep …
Read More »Chemical In Coffee May Prevent Obesity
Researchers have discovered that a chemical compound commonly found in coffee may help prevent some of the damaging effects of obesity. Scientists found that chlorogenic acid, or CGA, significantly reduced insulin resistance and accumulation of fat in the livers of mice who were fed a high-fat diet. The researchers believe …
Read More »A Hard Pill to Swallow?
A Hard Pill to Swallow? How to Make It a Little Easier to Take It’s a common complaint: previous research has indicated that more than half of all people experience swallowing difficulties when taking tablets or capsules. Now, a research brief offers some techniques to make hard-to-swallow pills go down a …
Read More »The Zio Event Card
The Zio Event Card The ZIO® Event Card is a prescription-only, single-use, disposable, looping ECG monitor that can be worn for up to 30 days. With the profile of three stacked credit cards and weighing less than 2 ounces, the ZIO Event Card is intended to be comfortable to wear …
Read More »Letter from the Editor, #756
When the first gastric bypass was done, the incision was about 6-9 inches long. Then came lap band surgery for weight loss. We have gone from 4 incisions to one small incision over the past five years. We are always looking for less-invasive ways to help our patients lose weight …
Read More »Editor’s Note, DCMS #215
A little over five years ago, a small company came to market with a low-dose rapid-acting dopamine receptor agonist with a claim that it could reset metabolism endpoints in the neuroendocrine system. Soon as prescribers heard the word “dopamine,” red flags went up and prescribing has gone nowhere. This week …
Read More »Handbook of Diabetes, 4th Ed., Excerpt #18: Hypertension in Diabetes
Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Diabetes and hypertension have been termed the ‘bad companions’ for cardiovascular disease risk. Diabetes alone increases this risk 2 – 4-fold; in the presence of hypertension, the risk for coronary heart disease is further trebled and for stroke, doubled. There is also …
Read More »Verapamil Studied in Prevention, Development of Diabetes
Trial will study calcium channel blocker thought to decrease protein production and protect against development of type 1 and type 2 diabetes…
Read More »New Approach Targets Type 2’s Poorly Controlled With Metformin
Add-on of saxagliptin plus dapagliflozin shows greater improvements in glycemic control versus the use of single drug with metformin…. Because of the progressive nature of the disease, patients with type 2 diabetes regularly require various antidiabetic agents to achieve and maintain glycemic control. This study assessed the efficacy and safety …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.